Június a nemzeti rákot túlélők hónapja, amikor is a daganatos betegség által érintettek előtt tisztelegünk és emlékezünk meg. Ezen időszak célja, hogy felhívjuk a figyelmet a betegségre, valamint támogatást nyújtsunk a jelenleg daganatos betegséggel küzdőknek.
E fontos ügy iránti elkötelezettségünk részeként összegyűjtöttünk egy olyan kiadványsorozatot, amely értékes betekintést nyújthat az oncothermia kezelésekbe. A lenti publikációk az mEHT alkalmazásának kedvező hatásaira koncentrálnak a túlélési idő és az életminőség javítása tekintetében.
Minnaar CA, Maposa I, Kotzen JA, Baeyens A. (2022)
Effects of modulated electro-hyperthermia (mEHT) on two and three year survival of locally advanced cervical cancer patients,
Cancers, 14, 656,
Ou J, Zhu X, Chen P, et al. (2020)
A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer,
Journal of Advanced Research, 24:175-182,
Fiorentini G, Sarti D, Casadei V, et.al. (2020)
Modulated electro-hyperthermia for the treatment of relapsed brain gliomas, in book Challenges and solutions of oncological hyperthermia,
ed. Szasz A., Ch. 6, pp.110-125, Cambridge Scholars,
Fiorentini G, Sarti D, Casadei V, et al. (2019)
Modulated electro-hyperthermia as palliative treatment for pancreas cancer: A retrospective observational study on 106 patients,
Integrative Cancer Therapies, Vol. 18:1-8,
Ou J, Zhu X, Chen P, et al. (2020)
A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer,
Journal of Advanced Research, 24:175-182,
Iyikesici MS. (2020)
Long-term survival outcomes of metabolically supported chemotherapy with Gemcitabine-based or FOLFIRINOX regimen combined with Ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in metastatic pancreatic cancer,
Complement Med Res, 27(1):31-39,
Iyikesici MS. (2020)
Survival outcomes of metabolically supported chemotherapy combined with Ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in advanced gastric cancer,
Nigerian Journal of Clinical Practice, 23:734-40,
Parmar G. (2018)
Naturopathic Anti-Tumoral Treatment & 8 Year Survival Benefit Statistics: A Single-Centre Experience;
Oncothermia Journal 24:405-425,
Ou J, Zhu X, Lu Y, et.al. (2017)
The safety and pharmacokinetics of high dose intravenous ascorbic acid synergy with modulated electrohyperthermia in Chinese patients with stage III-IV non-small cell lung cancer,
European J Pharmaceutical Sciences, 109:412-418,
Pang CLK, Zhang X, Wang Z, et.al. (2017)
Local modulated electro-hyperthermia in combination with traditional Chinese medicine vs. intraperitoneal chemoinfusion for the treatment of peritoneal carcinomatosis with malignant ascites: A phase II randomized trial,
Molecular and Clinical Oncology, 6:723-732,
Schirrmacher V, Stücker W, Lulei M, et.al. (2015)
Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report;
Immunotherapy 7: 855–860,
Reimnitz U. (2010)
Cholangiocellular carcinomas: survival without symptoms with hyperthermia – A case study.
Oncothermia Journal 1:20-22,
